NCT06370871: Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma |
|
|
| Not yet recruiting | 3 | 263 | NA | Brigimadlin, BI 907828, Ezabenlimab, BI 754091, Gemcitabine, Docetaxel | Boehringer Ingelheim | Advanced Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma (UPS), Myxofibrosarcoma (MFS) | 07/26 | 10/28 | | |
